Cognitive-behavioral management of chemotherapy-related cognitive change.
about
Non-pharmacological interventions for cognitive impairment due to systemic cancer treatmentNon-pharmacological interventions for cognitive impairment due to systemic cancer treatmentChemotherapy-related cognitive impairment in older patients with cancerDelivering care to long-term adult survivors of hematopoietic cell transplantation.What is known and unknown about chemotherapy-related cognitive impairment in patients with haematological malignancies and areas of needed research.AGO Recommendations for Diagnosis and Treatment of Patients with Primary and Metastatic Breast Cancer. Update 2011.Factors associated with quality of life of outpatients with breast cancer and gynecologic cancers and their family caregivers: a controlled studyMemory and cancer: a review of the literaturePrevalence, mechanisms, and management of cancer-related cognitive impairment.Cognitive effects of cancer systemic therapy: implications for the care of older patients and survivors.A meta-analysis of cognitive impairment following adult cancer chemotherapy.Meta-analysis of cognitive functioning in breast cancer survivors previously treated with standard-dose chemotherapy.Neuropsychological care and rehabilitation of cancer patients with chemobrain: strategies for evaluation and intervention development.Cancer- and treatment-related cognitive changes: what can we do now? What lies ahead?Symptom management of affective and cognitive disturbance with a group of cancer survivorsBehavioral symptoms in patients with breast cancer and survivors.Prospective neurocognitive function over 5 years after allogeneic hematopoietic cell transplantation for cancer survivors compared with matched controls at 5 yearsClinical characteristics, pathophysiology, and management of noncentral nervous system cancer-related cognitive impairment in adultsPsychological intervention for improving cognitive function in cancer survivors: a literature review and randomized controlled trial.Management of Cancer-related Cognitive Dysfunction-Conceptualization Challenges and Implications for Clinical Research and Practice.Clinical predictors of cognitive function in adults treated with hematopoietic cell transplantationSymptom burden and integrative medicine in cancer survivorship.Supportive care of hematopoietic cell transplant patientsLong-term survivorship at a price: late-term, therapy-associated toxicities in the adult hodgkin lymphoma patient.Predictors of neuropsychological change in patients with chronic myelogenous leukemia and myelodysplastic syndromeCognitive problems in patients on androgen deprivation therapy: a qualitative pilot study.Self-efficacy beliefs mediate the relationship between subjective cognitive functioning and physical and mental well-being after hematopoietic stem cell transplant.The Feasibility of Using Metacognitive Strategy Training to Improve Cognitive Performance and Neural Connectivity in Women with Chemotherapy-Induced Cognitive Impairment.A randomized trial of cognitive rehabilitation in cancer survivors.Cognitive and psychological factors associated with early posttreatment functional outcomes in breast cancer survivors.Searching for self: the layers and labels of panic disorder: a New Zealand study.Cognitive effects of cancer and its treatments at the intersection of aging: what do we know; what do we need to know?What You Do Not Know Could Hurt You: What Women Wish Their Doctors Had Told Them About Chemotherapy Side Effects on Memory and Response to AlcoholBreast cancer treatment and cognitive function: the current state of evidence, underlying mechanisms and potential treatments.Development of CBT for chemotherapy-related cognitive change: results of a waitlist control trial.Cognitive dysfunction and cancer: which consequences in terms of disease management?'Chemobrain': concentration and memory effects in people receiving chemotherapy - a descriptive phenomenological study.Chemotherapy and cognitive impairment: treatment options.Review of recent studies on interventions for cognitive deficits in patients with cancer.Chemotherapy-related cognitive impairment: does integrating complementary medicine have something to add? Review of the literature.
P2860
Q24193350-736F7DE7-F263-489B-AEC2-0CF1BF73A2F9Q26470426-D7AA0BCA-3205-4704-83B4-A68FFE956836Q26747612-03E3638D-EA4B-46C7-95E4-62BD9289AF0FQ27021501-6E77DA15-84B7-4F92-9557-41B1C5F62360Q30249112-98C8F01E-5361-4A6D-9C67-551EBDA84A86Q30318240-D8EC8825-AFE2-4DEF-AC2E-5425334A0449Q33288196-CB5DB96A-E48C-4F70-9F19-EFCC42AE4FD4Q33663544-B1152C3A-EB0B-442C-A44D-2E2026CB49E7Q33854977-9AB149C3-698E-4609-A15A-8B75C69C03C6Q34031141-2E9B184D-25C0-4D37-8438-ADCA8A1614FBQ34083459-1DDE8356-569F-4319-813B-04D0AB42C469Q34395112-3B241191-8C92-440C-87C9-67B7FB13F1C6Q34633028-0AD6E709-AF14-47DF-86EF-7E5203F2F7D5Q34669341-CFE57A38-D456-421E-88DF-5E69FACB13A6Q34674401-7CC8B344-DF31-4F38-BBF4-5F0D1341F650Q34675620-6BAB0473-4D42-471B-9D55-85ACA7BC0369Q35023468-D85E74DD-DF03-4EC0-ABB6-83CC5AE2ACC6Q35164117-1FF948FE-5A1E-4BE1-B0EC-590727AA2649Q35215913-E793042D-D5EA-49D8-B10B-47182EC7B8EEQ35427635-6A60B44D-CCCF-49EA-ACDC-F914B282FCE9Q35815463-BAA1193F-E439-48B2-BE0D-91FD880CF137Q36004562-BC735450-92AE-4C02-A1C8-3D97139763E7Q36243008-6859DE71-45E3-44AF-84E1-315E7D95D85CQ36612560-007D40E6-0573-4DDD-B230-A5903F1345A1Q36851043-6A710C07-A7CD-4A5E-8255-131618DC6175Q37038592-219C0968-1BFA-4D71-A326-0219777A1F92Q37211273-F7634E85-250D-4D3C-AE3F-1DC9DA7DF18FQ37242525-7BF68E2E-BB18-4A51-9FC9-D499E8740240Q37337976-323BF42E-64B6-4543-A67C-F87DCA6172D7Q37382652-E7EFBA9F-99DB-426F-9B1B-24DE89752268Q37418106-68CB7124-2C4B-4041-B47C-86146D72DDC6Q37431101-5CC02991-6DE8-46DB-9542-A303D078BF46Q37523813-9473E390-C749-4565-9CF1-8C0194345E2EQ37585300-B38AA0C5-6CCB-45C9-9111-BCA9045E7B3FQ37639152-9FC1DAEB-F3E6-41F7-B4B5-557995597390Q37831271-45402953-0C93-4493-931E-6DE0CEC3995EQ37858658-6049E033-B831-4D2A-AE08-97FA986952BFQ37911248-0E29F5EB-3011-43EC-9823-301A5854DBEAQ37982452-0B47423D-A128-462E-9F84-D0A2028039DBQ38036929-8430EA54-7CC9-48CF-BF7E-7788F98BA875
P2860
Cognitive-behavioral management of chemotherapy-related cognitive change.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Cognitive-behavioral management of chemotherapy-related cognitive change.
@ast
Cognitive-behavioral management of chemotherapy-related cognitive change.
@en
type
label
Cognitive-behavioral management of chemotherapy-related cognitive change.
@ast
Cognitive-behavioral management of chemotherapy-related cognitive change.
@en
prefLabel
Cognitive-behavioral management of chemotherapy-related cognitive change.
@ast
Cognitive-behavioral management of chemotherapy-related cognitive change.
@en
P2093
P2860
P356
P1433
P1476
Cognitive-behavioral management of chemotherapy-related cognitive change.
@en
P2093
Bernard F Cole
Charlotte T Furstenberg
Leila A Mott
Robert J Ferguson
Tim A Ahles
P2860
P304
P356
10.1002/PON.1133
P577
2007-08-01T00:00:00Z